GGrantIndex
← Leaderboards

Susan L. Neuhausen

University Of Utah

$19,099,097
Attributed
$28,862,138
Total exposure
11
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4.9M · FY200525
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$28,862,138 · 11

By mechanism

R01$22,477,896 · 7
U01$4,822,472 · 1
R56$839,093 · 1
R21$425,709 · 1
P30$296,968 · 1

Top collaborators

Most similar at University Of Utah

Same institution · by research overlap

Others in their field

Top investigators on “Base

Research focus

BaseCancer RiskDiagnosisVariantSamplingGenesMalignant NeoplasmsWomanResourcesFamilyIncidenceGeneticPredispositionCancer EtiologyPreventAffectMorbidity - Disease RateRisk AssessmentAfrican AmericanMalignant Breast NeoplasmDesignCase ControlFemaleCommunities

Grant awards (47)

Germline variation in homologous recombination repair genes in Hispanic/Latina women to predict breast cancer risk and response to treatment$4,307,388
R01 · FY2025 · MD
Environmental Chemical Body Burden and Prospective Breast Cancer Risk in the Cancer Prevention Study-3 Cohort$615,930
R01 · FY2025 · ES · contact PI
Environmental Chemical Body Burden and Prospective Breast Cancer Risk in the Cancer Prevention Study-3 Cohort$627,063
R01 · FY2024 · ES · contact PI
Environmental Chemical Body Burden and Prospective Breast Cancer Risk in the Cancer Prevention Study-3 Cohort$656,722
R01 · FY2023 · ES · contact PI
Environmental Chemical Body Burden and Prospective Breast Cancer Risk in the Cancer Prevention Study-3 Cohort$649,634
R01 · FY2022 · ES · contact PI
Cancer Control and Population Sciences$60,976
P30 · FY2022 · CA · contact PI
Cancer Control and Population Sciences$60,976
P30 · FY2021 · CA · contact PI
Cancer Control and Population Sciences$68,118
P30 · FY2020 · CA · contact PI
Menopausal transition - a window of susceptibility for the promotion of breast cancer by environmental exposures$891,750
U01 · FY2019 · ES
Cancer Control and Population Sciences$59,314
P30 · FY2019 · CA · contact PI
Menopausal transition - a window of susceptibility for the promotion of breast cancer by environmental exposures$945,498
U01 · FY2018 · ES
Germline and Tumor Genomic Analyses of Breast Cancer in Latinas$789,245
R01 · FY2018 · CA · contact PI
Cancer Control and Population Sciences$45,501
P30 · FY2018 · CA · contact PI
Cancer Control and Population Sciences$2,083
P30 · FY2018 · CA · contact PI
Menopausal transition - a window of susceptibility for the promotion of breast cancer by environmental exposures$977,907
U01 · FY2017 · ES
Germline and Tumor Genomic Analyses of Breast Cancer in Latinas$802,610
R01 · FY2017 · CA · contact PI
Menopausal transition - a window of susceptibility for the promotion of breast cancer by environmental exposures$989,046
U01 · FY2016 · ES
Germline and Tumor Genomic Analyses of Breast Cancer in Latinas$817,565
R01 · FY2016 · CA · contact PI
Menopausal transition - a window of susceptibility for the promotion of breast cancer by environmental exposures$1,018,271
U01 · FY2015 · ES
Germline and Tumor Genomic Analyses of Breast Cancer in Latinas$846,252
R01 · FY2015 · CA · contact PI
Germline and Tumor Genomic Analyses of Breast Cancer in Latinas$909,614
R01 · FY2014 · CA · contact PI
Genome-Wide Association Study in Celiac Disease$859,753
R01 · FY2011 · DK
Celiac Disease: Identifying Causal Variants from GWAS$839,093
R56 · FY2010 · DK · contact PI
Genome-Wide Association Study in Celiac Disease$753,221
R01 · FY2010 · DK
The IGF Signaling Pathway and Breast Cancer Risk$518,526
R01 · FY2010 · CA · contact PI
Genome-Wide Association Study in Celiac Disease$494,300
R01 · FY2010 · DK
Genome-Wide Association Study in Celiac Disease$735,221
R01 · FY2009 · DK · contact PI
The IGF Signaling Pathway and Breast Cancer Risk$502,157
R01 · FY2009 · CA · contact PI
Celiac Disease: From Genetic Risk to Disease Development$152,659
R21 · FY2009 · DK · contact PI
Celiac Disease: From Genetic Risk to Disease Development$71,550
R21 · FY2009 · DK · contact PI
The IGF Signaling Pathway and Breast Cancer Risk$525,564
R01 · FY2008 · CA · contact PI
Celiac Disease: From Genetic Risk to Disease Development$201,500
R21 · FY2008 · DK · contact PI
The IGF Signaling Pathway and Breast Cancer Risk$560,026
R01 · FY2007 · CA · contact PI
Genetic Epidemiology of Breast Cancer: BRCA1 and BRCA2$266,473
R01 · FY2007 · CA · contact PI
Genetic Epidemiology of Breast Cancer: BRCA1 and BRCA2$158,397
R01 · FY2007 · CA · contact PI
Genetic Epidemiology of Breast Cancer: BRCA1 and BRCA2$561,838
R01 · FY2006 · CA · contact PI
MAPPING AND CLONING OF NON-HLA GENES FOR CELIAC DISEASE$665,632
R01 · FY2005 · DK
Genetic Epidemiology of Breast Cancer: BRCA1 and BRCA2$561,474
R01 · FY2005 · CA
MAPPING AND CLONING OF NON-HLA GENES FOR CELIAC DISEASE$642,161
R01 · FY2004 · DK
Genetic Epidemiology of Breast Cancer: BRCA1 and BRCA2$545,576
R01 · FY2004 · CA
MAPPING AND CLONING OF NON-HLA GENES FOR CELIAC DISEASE$642,061
R01 · FY2003 · DK
Genetic Epidemiology of Breast Cancer: BRCA1 and BRCA2$545,271
R01 · FY2003 · CA
MAPPING AND CLONING OF NON-HLA GENES FOR CELIAC DISEASE$666,268
R01 · FY2002 · DK
GENETIC EPIDEMIOLOGY OF BREAST CANCER--BRCA1 AND BRCA2$316,712
R01 · FY2002 · CA
GENETIC EPIDEMIOLOGY OF BREAST CANCER--BRCA1 AND BRCA2$456,075
R01 · FY2001 · CA
MAPPING OF NON-HLA LOCI FOR GLUTEN SENSITIVE ENTEROPATHY$36,867
R01 · FY2001 · DK
GENETIC EPIDEMIOLOGY OF BREAST CANCER--BRCA1 AND BRCA2$442,300
R01 · FY2000 · CA